Company / Tangible Book Value per Share
Myriad Genetics, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$3.90
FY2025
5-year range
$3.90 / $10.32
FY2021-FY2025
Trend
-24.8%
vs FY2024
Sector context
#113 of 209
Health Care
What the data says
At $3.90, Myriad Genetics, Inc.'s tangible book value per share ranks #113 of 209 in the Health Care sector. Tangible Book Value per Share has declined for 4 consecutive years, from $10.32 in FY2021 to $3.90 in FY2025.
Based on SEC 10-K filings.
3.90 in FY2025 with a 5-year CAGR of -13.5%.
Declined from $6.58 to $3.90 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -21.8%
- 5-Year CAGR
- -13.5%
- 10-Year CAGR
- -
Sector benchmark
#113 of 209 in Health CareTop 54% of 209This company $3.90 Sector average $119.74
▼
-96.7% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s tangible book value per share has declined for 4 consecutive years.
- In FY2025, tangible book value per share decreased 24.8% year-over-year.
- Ranks #113 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.90 | -24.8% |
| FY2024 | $5.18 | -21.1% |
| FY2023 | $6.58 | -19.3% |
| FY2022 | $8.15 | -21.0% |
| FY2021 | $10.32 | +27.9% |
| FY2020 | $8.07 | -27.6% |
| FY2019 | $11.15 | +18.6% |
| FY2018 | $9.40 | +52.7% |
| FY2017 | $6.15 | -8.9% |
| FY2016 | $6.75 | +15.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026